Member Info for MoneyThimbles

This is very disappointing. At today's price, it's worth less than just the cash part of the CEPSA deal. Every time in the last year that I've had a chance to sell in the market, and not taken it, I've regretted it. This BoD really can snatch defeat from the jaws of victory. I guess they'll be OK though, snouts firmly attached to the Ophir teat.

Maybe I'm easily impressed but that did seem to be a very exciting presentation: IP in place, better results than any of the competition, products moving through the regulatory processes on time, management anticipating what needs to be done and doing it, and a future of enormous opportunities of which the current line-up is only the tiniest fragment -- my only remaining fear was that someone would snap us up too soon! That said, you could see that even as the money starts to come in, there will be plenty of opportunities to spend it, e.g. on expensive American trials for new products. They do seem to be pursuing their opportunities in an intelligent order though, so I have high hopes for efficient use of funds.

Made a nasty, cheap, lowball offer at a difficult time. Frac 'em. Once the SONA deal is done, the cheapness of this share will become apparent.

But shouldn't all this cheap oil be stimulating global demand like anything? I remember reading that cheap oil is particularly stimulating because its use as fuel means prices fall in all parts of the economy. I'd be looking for the first effects of that beginning to be felt at the end of this quarter, with the numbers starting to appear by the middle of next year.

I just find it slightly odd that we haven't heard *anything* at all about firm numbers. It was the same with the process that lead to the SONA deal: no numbers, until we were presented with a fait accompli. I'm surely a comparative newbie, but I've never been in a share where the takeover negotiations were so opaque.

They'll ultimately be for whatever is in the company when the deal is agreed, if it is. At the moment, the SONA deal hasn't even been put to the shareholders yet, never mind agreed by them, so any negotiations would presumably be for the whole thing -- however, the BoD will be able to say that if Ophir or SEPSA take too long to come up with an acceptable offer, they will risk losing the Bualuang stuff.

It *should* be positive, confirming that this company is indeed worth much more than its current s.p. implies. How the market will take it is anybody's guess, unfortunately.

In the Chairman's statement: "As a result of the increase in turnover, we have also experienced a substantial increase in the working capital requirement to fund the increased debtors and stock requirements." Looks like he's hinting at a cash call.

It's not just that. Google Finance is showing yesterday's price as under a penny and today's price as 73p, something like 75 times yesterday's. So is that 5x for the consolidation and 15x for the court case news (5x15=75)? Or have we changed from being quoted in euro to being quoted in pennies, or something?

Well it's not dilution if everyone gets it, it's just equivalent I suppose to a partial share split. OTOH, if not everyone has been able to take it up, what with the presumably active secondary market, then I'm actually gaining, just not a full 5%. OTOOH it's almost too small to worry about.

Just let me get my free shares before they start overpaying for everything -- or at least before the consequences start being felt.

That makes encouraging reading, NR. I especially liked this bit: "“A knee repair can cost the NHS from £7,000 to £8,000, our process could produce savings of 50 per cent,” estimates TRX’s chief executive Antony Odell. "

If you take off the 11p/share capital return, then we are already back under a quid :(